Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study. (linkinghub.elsevier.com)

Authors: Palomba ML … Morschhauser F Journal: The Lancet Published: 2026-03-07 DOI: https://doi.org/10.1016/S0140-6736(25)02435-3